NCT Number: NCT00196911
STN-Stimulation Versus Best Medical Treatment in Advanced PD
Assessment of the therapeutic effect of deep brain stimulation of the subthalamic nucleus compared with drug treatment alone in patients with advanced Parkinson's disease.
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Neurologische Klinik der Charité, Augustenburgerplatz 1, Berlin, Germany
About this study
Patients are randomized either to medical treatment or subthalamic stimulation. The observation period was 6 months. The primary outcome criterium: PDQ-39 and UPDRS III.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
advanced Parkinson's disease with UPDRS III score >29/104 or Dyskinesia score > 2 or tremor >2
Exclusion criteria
age>75 years depression psychosis surgical contraindications
Treatment and study plan
Primary outcomes
-
Quality of life
-
Motor Score in the OFF (UPDRS III)
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
German Parkinson Study Group (GPS)
Other
Registry information
Official study title
Randomized, Multicenter, Prospective, Parallel-Group Study of the Effect of Deep Brain Stimulation (Subthalamic Nucleus) on Quality of Life and Motor Complications in Patients With Advanced Parkinson's Disease Compared With Best Medical Treatment
Important dates
- Study start
- 2001
- Study completion
- 2005
- First posted
- Sep 20, 2005
- Registry last updated
- Nov 30, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Clinical Laboratory Evaluation of Chronic Autonomic Failure
NCT03648905
Autonomic Failure, Autonomic Nervous System Diseases
Bethesda, Maryland, United States
View Trial DetailsPET Scanning in Parkinson s Disease
NCT00024622
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsPhysiological Investigations of Movement Disorders
NCT01019343
Basal Ganglia Diseases, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsAnalysis of the Enteric Nervous System Using Colonic Biopsies
NCT01353183
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Nantes, France
View Trial Details